tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Technical Analysis

72 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Design Therapeutics’s (DSGN) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting Design Therapeutics is a Sell.
Design Therapeutics’s (DSGN) 20-Day exponential moving average is 3.82, while Design Therapeutics’s (DSGN) share price is $4.46, making it a Buy.
Design Therapeutics’s (DSGN) 50-Day exponential moving average is 3.77, while Design Therapeutics’s (DSGN) share price is $4.46, making it a Buy.

Design Therapeutics (DSGN) Pivot Points

Jul 18, 2024, 02:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.02
4.16
4.32
4.46
4.62
4.76
4.92
Fibonacci
4.16
4.27
4.34
4.46
4.57
4.65
4.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Design Therapeutics (DSGN) Moving Averages

Jul 18, 2024, 02:28 AM
Period
Simple
Exponential
MA5
4.25Buy
4.26Buy
MA10
3.81Buy
3.99Buy
MA20
3.60Buy
3.82Buy
MA50
3.94Buy
3.77Buy
MA100
3.65Buy
3.62Buy
MA200
2.99Buy
3.39Buy
Design Therapeutics’s (DSGN) 10-Day exponential moving average is 3.99, while Design Therapeutics’s (DSGN) share price is $4.46, making it a Buy.
Design Therapeutics’s (DSGN) 100-Day exponential moving average is 3.62, while Design Therapeutics’s (DSGN) share price is $4.46, making it a Buy.
Design Therapeutics’s (DSGN) stock price is $4.46 and Design Therapeutics’s (DSGN) 50-day simple moving average is 3.94, creating a Buy signal.
Design Therapeutics’s (DSGN) stock price is $4.46 and Design Therapeutics’s (DSGN) 100-day simple moving average is 3.65, creating a Buy signal.
Design Therapeutics’s (DSGN) stock price is $4.46 and Design Therapeutics’s (DSGN) 200-day simple moving average is 2.99, creating a Buy signal.

Design Therapeutics (DSGN) Technical Indicators

Jul 18, 2024, 02:28 AM
Name
Value
Implied Action
RSI (14)
72.02
Sell
STOCH (9,6)
89.19
Sell
STOCHRSI (14)
89.19
Sell
MACD (12,26)
0.13
Sell
ADX (14)
24.29
Neutral
Williams %R
-9.97
Sell
CCI (14)
194.67
Sell
ATR (14)
0.25
-
Ultimate Oscillator
62.44
Neutral
ROC
37.46
Buy
Design Therapeutics’s (DSGN) Relative Strength Index (RSI) is 72.02, creating a Sell signal.
Design Therapeutics’s (DSGN) Trend Strength Indicator (ADX) is 24.29, creating a Neutral signal.
Design Therapeutics’s (DSGN) Commodity Channel Index (CCI) is 194.67, creating a Sell signal.
Design Therapeutics’s (DSGN) Price Rate of Change (ROC) is 37.46, creating a Buy signal.

FAQ

Is DSGN a Buy, Hold, or Sell?
Based on DSGN’s technical indicators, DSGN is a Buy.
    What is DSGN’s RSI (14)?
    DSGN’s RSI (14) is 72.02, which suggests DSGN is a Sell.
      What is DSGN’s MACD?
      DSGN’s MACD is 0.13, which suggests DSGN is a Sell.
        What is DSGN’s 5-day moving average?
        DSGN’s 5-day moving average is 4.25, which suggests DSGN is a Buy.
          What is DSGN’s 20-day moving average?
          DSGN 20-day moving average is 3.60, which suggests DSGN is a Buy.
            What is DSGN’s 50-day moving average?
            DSGN’s 50-day moving average is 3.94, which suggests DSGN is a Buy.
              What is DSGN’s 200-day moving average?
              DSGN’s 200-day moving average is 2.99, which suggests DSGN is a Buy.
                What is DSGN’s Williams % R (14)?
                DSGN’s Williams % R (14) is -9.97, which suggests DSGN is a Sell.
                  What is DSGN’s CCI (14)?
                  DSGN’s CCI (14) is 194.67, which suggests DSGN is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis